PMID- 31435014 OWN - NLM STAT- MEDLINE DCOM- 20200225 LR - 20240204 IS - 1476-4687 (Electronic) IS - 0028-0836 (Print) IS - 0028-0836 (Linking) VI - 572 IP - 7771 DP - 2019 Aug TI - Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. PG - 665-669 LID - 10.1038/s41586-019-1501-z [doi] AB - Intestinal commensal bacteria can inhibit dense colonization of the gut by vancomycin-resistant Enterococcus faecium (VRE), a leading cause of hospital-acquired infections(1,2). A four-strained consortium of commensal bacteria that contains Blautia producta BP(SCSK) can reverse antibiotic-induced susceptibility to VRE infection(3). Here we show that BP(SCSK) reduces growth of VRE by secreting a lantibiotic that is similar to the nisin-A produced by Lactococcus lactis. Although the growth of VRE is inhibited by BP(SCSK) and L. lactis in vitro, only BP(SCSK) colonizes the colon and reduces VRE density in vivo. In comparison to nisin-A, the BP(SCSK) lantibiotic has reduced activity against intestinal commensal bacteria. In patients at high risk of VRE infection, high abundance of the lantibiotic gene is associated with reduced density of E. faecium. In germ-free mice transplanted with patient-derived faeces, resistance to VRE colonization correlates with abundance of the lantibiotic gene. Lantibiotic-producing commensal strains of the gastrointestinal tract reduce colonization by VRE and represent potential probiotic agents to re-establish resistance to VRE. FAU - Kim, Sohn G AU - Kim SG AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Weill Cornell Medical College, New York, NY, USA. FAU - Becattini, Simone AU - Becattini S AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Moody, Thomas U AU - Moody TU AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Shliaha, Pavel V AU - Shliaha PV AD - Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Littmann, Eric R AU - Littmann ER AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Seok, Ruth AU - Seok R AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Gjonbalaj, Mergim AU - Gjonbalaj M AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Eaton, Vincent AU - Eaton V AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Fontana, Emily AU - Fontana E AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Amoretti, Luigi AU - Amoretti L AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Wright, Roberta AU - Wright R AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Caballero, Silvia AU - Caballero S AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Weill Cornell Medical College, New York, NY, USA. FAU - Wang, Zhong-Min X AU - Wang ZX AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Jung, Hea-Jin AU - Jung HJ AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Morjaria, Sejal M AU - Morjaria SM AD - Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Leiner, Ingrid M AU - Leiner IM AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Qin, Weige AU - Qin W AD - Donald B. and Catherine C. Marron Cancer Metabolism Center, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Ramos, Ruben J J F AU - Ramos RJJF AD - Donald B. and Catherine C. Marron Cancer Metabolism Center, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Cross, Justin R AU - Cross JR AD - Donald B. and Catherine C. Marron Cancer Metabolism Center, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Narushima, Seiko AU - Narushima S AD - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. FAU - Honda, Kenya AU - Honda K AD - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. AD - JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan. AD - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. FAU - Peled, Jonathan U AU - Peled JU AD - Weill Cornell Medical College, New York, NY, USA. AD - Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Hendrickson, Ronald C AU - Hendrickson RC AD - Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Taur, Ying AU - Taur Y AD - Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - van den Brink, Marcel R M AU - van den Brink MRM AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. AD - Weill Cornell Medical College, New York, NY, USA. AD - Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. FAU - Pamer, Eric G AU - Pamer EG AD - Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. egpamer@uchicago.edu. AD - Weill Cornell Medical College, New York, NY, USA. egpamer@uchicago.edu. AD - Lucille Castori Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY, USA. egpamer@uchicago.edu. AD - Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. egpamer@uchicago.edu. LA - eng GR - U01 AI124275/AI/NIAID NIH HHS/United States GR - T34 GM007823/GM/NIGMS NIH HHS/United States GR - S10 OD010598/OD/NIH HHS/United States GR - P30 CA008748/CA/NCI NIH HHS/United States GR - R01 AI095706/AI/NIAID NIH HHS/United States GR - R01 AI042135/AI/NIAID NIH HHS/United States GR - T32 GM007739/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20190821 PL - England TA - Nature JT - Nature JID - 0410462 RN - 0 (Anti-Bacterial Agents) RN - 0 (Bacteriocins) RN - 1414-45-5 (Nisin) RN - 6Q205EH1VU (Vancomycin) SB - IM MH - Animals MH - Anti-Bacterial Agents/biosynthesis/isolation & purification/metabolism/pharmacology MH - Bacteriocins/genetics/isolation & purification/*metabolism/*pharmacology MH - Enterococcus faecium/*drug effects/growth & development/isolation & purification MH - Feces/microbiology MH - Female MH - Gastrointestinal Tract/drug effects/microbiology MH - Germ-Free Life MH - Gram-Positive Bacteria/drug effects/growth & development MH - Humans MH - Lactococcus lactis/chemistry/growth & development/*metabolism/physiology MH - Mice MH - Microbial Sensitivity Tests MH - Microbiota/genetics MH - Nisin/chemistry/pharmacology MH - *Probiotics MH - Symbiosis/drug effects MH - Vancomycin/pharmacology MH - Vancomycin Resistance/*drug effects MH - Vancomycin-Resistant Enterococci/*drug effects/growth & development/isolation & purification PMC - PMC6717508 MID - NIHMS1535496 EDAT- 2019/08/23 06:00 MHDA- 2020/02/26 06:00 PMCR- 2020/02/21 CRDT- 2019/08/23 06:00 PHST- 2018/10/22 00:00 [received] PHST- 2019/07/22 00:00 [accepted] PHST- 2019/08/23 06:00 [pubmed] PHST- 2020/02/26 06:00 [medline] PHST- 2019/08/23 06:00 [entrez] PHST- 2020/02/21 00:00 [pmc-release] AID - 10.1038/s41586-019-1501-z [pii] AID - 10.1038/s41586-019-1501-z [doi] PST - ppublish SO - Nature. 2019 Aug;572(7771):665-669. doi: 10.1038/s41586-019-1501-z. Epub 2019 Aug 21.